INHALE-3 extension study: Inhaled technosphere insulin plus insulin degludec maintains glycemic control
A new study in the journal Diabetes Technology & Therapeutics evaluated the effects of a regimen of inhaled technosphere ...
Healio4d
Inhaled insulin lowers HbA1c at 30 weeks in adults with type 1 diabetes
Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...
EurekAlert!3d
Results of the INHALE-3 extension study: inhaled technosphere insulin plus insulin degludec in T1D
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the effects of a regimen of inhaled technosphere insulin (TI) and insulin degludec over 30 weeks and its ...